This is just the start of what should be a number of locations...

This is just the start of what should be a number of locations adopting Imricor products and as time goes on these leading centres of excellence will flow down to the next level of centres.
the company is in the strongest position to execute on this opportunity with both the software imaging Northstar and
consumable catheters which will lead to increased revenue.
we also have to remember that Atrial flutter is only one indication and once IMR is approved for Atrial fribulation and VT (Ventricular Tachicardia) the market opportunity grows enormously.
anotber great step in right direction and we are also Seeing some volume creep into stock too